Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 15.71
+0.03 (0.19%)
Apr 25, 2025, 2:45 PM CST
Hualan Biological Vaccine Revenue
In the year 2024, Hualan Biological Vaccine had annual revenue of 1.13B CNY, down -53.21%. Hualan Biological Vaccine had revenue of 170.45M in the quarter ending December 31, 2024, a decrease of -75.37%.
Revenue
1.13B
Revenue Growth
-53.21%
P/S Ratio
8.29
Revenue / Employee
1.51M
Employees
748
Market Cap
9.35B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.62B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |